Shanghai InnoStar Bio-tech Co., Ltd. (SHA:688710)

SHA:688710 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	1,433	1,287	1,370	1,158	1,255	638.77
Short-Term Investments	-	-	-	-	-	12.33
Cash & Short-Term Investments	1,433	1,287	1,370	1,158	1,255	651.1
Cash Growth	14.27%	-6.02%	18.25%	-7.69%	92.70%	223.82%
Accounts Receivable	463.74	329.62	359.88	273.91	228.07	139.5
Other Receivables	9.43	8.26	22.74	17.81	6.06	-
Receivables	473.17	337.88	382.62	291.72	234.13	139.54
Inventory	650.47	430.46	332.02	510.54	489.47	396.85
Other Current Assets	235.45	123.16	83.83	25.51	34.48	68.05
Total Current Assets	2,792	2,179	2,168	1,986	2,013	1,256
Property, Plant & Equipment	902.08	786.74	752.24	438.88	444.53	443.69
Other Intangible Assets	101.21	103.57	105.52	109.47	10.91	5.39
Long-Term Deferred Tax Assets	25.6	25.32	17.94	13.21	7.78	7.58
Long-Term Deferred Charges	62.39	66.8	70.45	77.02	81.57	73.78
Other Long-Term Assets	53.16	92.42	105.37	150.86	60.72	16.62
Total Assets	3,937	3,253	3,220	2,775	2,618	1,803

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	101.44	69	46.82	83.99	59.4	83.53
Accrued Expenses	47.47	86.29	75.88	75.29	65.6	60.73
Short-Term Debt	-	-	0.5	8.01	-	-
Current Portion of Long-Term Debt	15.83	-	-	-	-	39.06
Current Portion of Leases	-	11.09	29.28	23.39	17.57	17.91
Current Income Taxes Payable	7.96	-	5.12	2.98	7.13	9.46
Current Unearned Revenue	951.7	456.45	347.3	607.29	722	534.11
Other Current Liabilities	182.12	89.36	63.46	80.36	30	20.76
Total Current Liabilities	1,307	712.19	568.37	881.31	901.71	765.57
Long-Term Leases	105.89	104.59	201.32	215.1	229.23	239.28
Long-Term Unearned Revenue	62.7	68.47	41.34	38.78	45.76	43.34
Other Long-Term Liabilities	4.97	6.16	6.39	0.76	-	0
Total Liabilities	1,480	891.41	817.42	1,136	1,177	1,048

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	140.98	140.98	140.98	105.73	105.73	87.13
Additional Paid-In Capital	1,702	1,696	1,688	1,098	1,081	475.48
Retained Earnings	580.99	486.97	562.6	414.83	220.38	134.38
Comprehensive Income & Other	-0.97	-0.34	0.06	-	-	-
Total Common Equity	2,423	2,323	2,392	1,618	1,407	696.99
Minority Interest	33.53	38.58	10.19	21.42	34.35	57.43
Shareholders' Equity	2,457	2,362	2,402	1,639	1,442	754.41
Total Liabilities & Equity	3,937	3,253	3,220	2,775	2,618	1,803

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	121.73	115.68	231.1	246.5	246.8	296.25
Net Cash (Debt)	1,312	1,171	1,138	911.73	1,008	354.85
Net Cash Growth	16.18%	2.89%	24.87%	-9.54%	184.03%	119.03%
Net Cash Per Share	9.86	8.45	9.71	8.63	10.42	4.83
Filing Date Shares Outstanding	141.15	140.98	140.98	105.73	96.72	87.13
Total Common Shares Outstanding	141.15	140.98	140.98	105.73	96.72	87.13
Working Capital	1,486	1,466	1,600	1,105	1,111	489.97
Book Value Per Share	17.17	16.48	16.97	15.30	14.55	8.00
Tangible Book Value	2,322	2,220	2,286	1,509	1,396	691.59
Tangible Book Value Per Share	16.45	15.75	16.22	14.27	14.44	7.94
Buildings	-	232.08	103.59	44.04	25.53	24.35
Machinery	-	453.42	379.74	316.83	288.03	223.18
Construction In Progress	-	225.52	239.02	40.75	0.28	0.3

Data Source: S&P Global Market Intelligence Last updated: Oct 26, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 28, 2026

Data Sources Report a data error